TG Therapeutics, Inc. (NASDAQ:TGTX) Receives $50.00 Consensus Price Target from Brokerages
Shares of TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six research firms that are presently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a […]
17 Feb 06:08 · The Markets Daily